Global Aesthetics Strong global presence with products in over 70 countries and a leadership position in aesthetic medicine presents opportunities to expand distribution partnerships, channel sales, and co-marketing initiatives with clinics and medispas in new regions.

Award Winning Flagship injectable RRS HA LONG LASTING has won Best Injectable in the Skin Revitalization category at AMWC 2026, signaling a proven, premium product that can be leveraged in sales pitches, reseller agreements, and bundled offers to attract high-end clients.

R&D Focus In-house R&D and continuous formulation innovation suggest potential for collaboration on custom cosmeceutical solutions, private-label opportunities, and Joint Development Agreements to meet specific practitioner needs.

Expansion Footprint Recent participation in major industry events and ongoing growth into the pharmaceutical sector indicate readiness to explore strategic partnerships, clinical research collaborations, and broader product diversification with hospital systems and specialty distributors.

Mid-Market Potential Current revenue range and mid-sized employee base imply attainable cross-sell opportunities across adjacent segments such as devices, injectables, and advanced cosmeceuticals for clinics seeking comprehensive aesthetic portfolios.